Published in Nature on May 10, 1985
Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J (1985) 6.31
Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol (1988) 5.21
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A (1989) 5.07
The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J (1991) 4.96
An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol (1988) 4.08
Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences. Mol Cell Biol (1987) 3.99
Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci U S A (1987) 3.74
Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J (1986) 3.69
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A (1988) 3.23
Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci U S A (1986) 3.19
Transcription of the human hsp70 gene is induced by serum stimulation. Proc Natl Acad Sci U S A (1985) 2.76
Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol (1990) 2.64
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J (1985) 2.53
Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol Cell Biol (1985) 2.49
Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci U S A (1988) 2.32
Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNa stability. EMBO J (1985) 2.10
An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol (1995) 2.08
Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1. Mol Cell Biol (1988) 2.08
Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol (1987) 1.86
Cell cycle expression of RNA duplex unwindase activity in mammalian cells. Mol Cell Biol (1988) 1.86
c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Mol Cell Biol (1986) 1.85
The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J (1986) 1.80
c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol Cell Biol (1988) 1.76
Multiple mechanisms regulate c-myc gene expression during normal T cell activation. EMBO J (1988) 1.66
Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene. Mol Cell Biol (1987) 1.63
Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells. Blood (2009) 1.62
Major substrate for growth factor-activated protein-tyrosine kinases is a low-abundance protein. Mol Cell Biol (1985) 1.61
Retracted A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J (2007) 1.58
Periodic cdc25C transcription is mediated by a novel cell cycle-regulated repressor element (CDE). EMBO J (1995) 1.54
Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1986) 1.53
Asynchronous DNA replication within the human beta-globin gene locus. Proc Natl Acad Sci U S A (1988) 1.47
Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer. Mol Cell Biol (1988) 1.45
Murine dihydrofolate reductase transcripts through the cell cycle. Mol Cell Biol (1986) 1.43
Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle. EMBO J (1986) 1.41
Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol Cell Biol (1986) 1.40
The human cut homeodomain protein represses transcription from the c-myc promoter. Mol Cell Biol (1994) 1.40
Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest (1988) 1.39
Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J (1994) 1.37
Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol (1985) 1.36
Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol Cell Biol (1996) 1.35
alpha-Thrombin-induced early mitogenic signalling events and G0 to S-phase transition of fibroblasts require continual external stimulation. EMBO J (1985) 1.34
The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc Natl Acad Sci U S A (1985) 1.34
Growth-dependent synthesis of c-myc-encoded proteins: early stimulation by serum factors in synchronized mouse 3T3 cells. Mol Cell Biol (1985) 1.34
Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol Cell Biol (1985) 1.33
Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages. EMBO J (1986) 1.30
Role of the promoter in the regulation of the thymidine kinase gene. Mol Cell Biol (1988) 1.27
Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle. J Cell Biol (1985) 1.27
c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment. Proc Natl Acad Sci U S A (1985) 1.24
Structure, expression and regulation of the murine 4F2 heavy chain. Nucleic Acids Res (1989) 1.23
Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J Virol (1987) 1.20
Relatively stable population of c-myc RNA that lacks long poly(A). Mol Cell Biol (1987) 1.17
Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med (1986) 1.15
C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development. EMBO J (1986) 1.13
Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin. Proc Natl Acad Sci U S A (1986) 1.12
Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol Biol Cell (1994) 1.10
Permanent expression of p53 in FR 3T3 rat cells but cell cycle-dependent association with large-T antigen in simian virus 40 transformants. EMBO J (1985) 1.10
Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice. Mol Cell Biol (1986) 1.10
Transcriptional and posttranscriptional mechanisms regulate murine thymidine kinase gene expression in serum-stimulated cells. Mol Cell Biol (1988) 1.09
Genetic analysis of the human thymidine kinase gene promoter. Mol Cell Biol (1986) 1.09
Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol Cell Biol (1986) 1.07
Altered expression of G1-specific genes in human malignant myeloid cells. Proc Natl Acad Sci U S A (1986) 1.07
Varied interactions between proviruses and adjacent host chromatin. Mol Cell Biol (1986) 1.07
c-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer (1989) 1.06
Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells. Proc Natl Acad Sci U S A (1987) 1.05
Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein. Mol Biol Cell (1994) 1.04
Regulation of the transcript for a lysosomal protein: evidence for a gene program modified by platelet-derived growth factor. Mol Cell Biol (1985) 1.04
Nuclear colocalization of cellular and viral myc proteins with HSP70 in myc-overexpressing cells. J Virol (1991) 1.03
c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. Am J Pathol (1988) 1.03
Regulation of thymidine kinase protein levels during myogenic withdrawal from the cell cycle is independent of mRNA regulation. Nucleic Acids Res (1988) 1.03
The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Br J Cancer (1986) 1.01
Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol (1993) 1.01
Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J (1998) 1.00
Immunochemical detection of proteins related to the human c-myc exon 1. EMBO J (1986) 1.00
Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression. Mol Cell Biol (1987) 0.99
A cell cycle analysis of growth-related genes expressed during T lymphocyte maturation. J Cell Biol (1990) 0.98
Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol Cell Biol (1992) 0.96
CSF-1-induced gene expression in macrophages: dissociation from the mitogenic response. EMBO J (1987) 0.96
Induction of DNA replication by transcription in the region upstream of the human c-myc gene in a model replication system. Mol Cell Biol (1996) 0.94
Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis. J Clin Pathol (1987) 0.93
Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis. Mol Cell Biol (1986) 0.92
Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysis. EMBO J (1986) 0.89
Cell cycle-dependent changes in conformation and composition of nucleosomes containing human histone gene sequences. Nucleic Acids Res (1987) 0.87
Two-step stimulation of B lymphocytes to enter DNA synthesis: synergy between anti-immunoglobulin antibody and cytochalasin on expression of c-myc and a G1-specific gene. Mol Cell Biol (1988) 0.85
Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. Br J Pharmacol (1996) 0.84
Primase p49 mRNA expression is serum stimulated but does not vary with the cell cycle. Mol Cell Biol (1989) 0.82
Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb. Biochem J (2000) 0.82
Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone. Br J Cancer (1992) 0.81
Model for intermediate steps in monocytic differentiation: c-myc, c-fms, and ferritin as markers. Proc Natl Acad Sci U S A (1987) 0.81
The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells. J Clin Invest (1995) 0.81
Isolation of Genes that Are Preferentially Expressed at the G(1)/S Boundary during the Cell Cycle in Synchronized Cultures of Catharanthus roseus Cells. Plant Physiol (1991) 0.81
p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol (1994) 0.81
Phase-Specific Polypeptides and Poly(A) RNAs during the Cell Cycle in Synchronous Cultures of Catharanthus roseus Cells. Plant Physiol (1989) 0.80
Structural and functional analysis of an alternatively spliced chicken TK messenger RNA. Nucleic Acids Res (1986) 0.80
Adenosine deaminase mRNA expression is regulated posttranscriptionally during differentiation of HL-60 cells. Nucleic Acids Res (1987) 0.80
Differential control of proto-oncogene c-myc and c-fos expression in lymphocytes and fibroblasts. Biochem J (1987) 0.79
Enhanced c-myc gene expression during forelimb regenerative outgrowth in the young Xenopus laevis. Proc Natl Acad Sci U S A (1990) 0.79
Inference of cell cycle-dependent proteolysis by laser scanning cytometry. Exp Cell Res (2009) 0.79
In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters. Mol Cell Biol (1992) 0.79
Rodent cell transformation and immediate early gene expression following 60-Hz magnetic field exposure. Environ Health Perspect (1996) 0.79
Prognostic significance of "short-term" effects of chemotherapy on MYC and histone H3 mRNA levels in acute leukemia patients. Proc Natl Acad Sci U S A (1988) 0.78
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (2001) 23.42
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19
Chromosomal subunits in active genes have an altered conformation. Science (1976) 14.63
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I. Cell (1980) 12.78
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell (1995) 8.75
Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell (1997) 8.61
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev (2000) 8.35
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (1986) 7.19
Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93
The B7 and CD28 receptor families. Immunol Today (1994) 6.38
Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature (1982) 6.11
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity (1995) 5.77
An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol (1996) 5.74
BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev (2001) 5.66
Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49
A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47
Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res (1987) 5.46
Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature (1981) 5.39
Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol (2001) 5.10
Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science (1985) 5.08
Role of the CD28 receptor in T-cell activation. Immunol Today (1990) 4.89
Hb switching in chickens. Cell (1980) 4.88
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol (1987) 4.76
Looping versus linking: toward a model for long-distance gene activation. Genes Dev (1999) 4.63
Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res (1991) 4.60
Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature (1997) 4.55
Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell (1999) 4.55
Alpha-Globin-gene switching during the development of chicken embryos: expression and chromosome structure. Cell (1981) 4.47
Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev (1995) 4.30
A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev (1990) 4.30
Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci U S A (1995) 4.22
The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev (1992) 4.20
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell (2000) 4.10
Human fetal to adult hemoglobin switching: changes in chromatin structure of the beta-globin gene locus. Proc Natl Acad Sci U S A (1983) 4.05
Bax-independent inhibition of apoptosis by Bcl-XL. Nature (1996) 3.82
c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (1985) 3.72
T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol (2001) 3.59
A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J (1996) 3.57
Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science (1987) 3.49
An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA. Mol Cell Biol (1991) 3.48
Expression of the c-myb proto-oncogene during cellular proliferation. Nature (1986) 3.45
Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci U S A (1995) 3.44
Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev (1996) 3.40
IL-7 enhances the survival and maintains the size of naive T cells. J Immunol (2001) 3.39
Transcription elongation and eukaryotic gene regulation. Oncogene (1990) 3.34
bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (1994) 3.34
Bone-marrow transplantation (first of two parts). N Engl J Med (1975) 3.33
Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. Genes Dev (1998) 3.33
Characterization of XIAP-deficient mice. Mol Cell Biol (2001) 3.32
Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol (1998) 3.32
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev (2000) 3.27
Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci U S A (1994) 3.26
Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J Biol Chem (2001) 3.22
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol (1999) 3.17
Molecular analysis of the human beta-globin locus activation region. Proc Natl Acad Sci U S A (1989) 3.17
CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol Cell Biol (1993) 3.08
Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol Cell (2000) 3.03
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci (2000) 3.00
Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J Immunol (1997) 2.98
Measurement of endogenous leukosis virus nucleotide sequences in the DNA of normal avian embryos by RNA-DNA hybridization. Virology (1973) 2.94
Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med (1995) 2.94
Identification of a telomeric DNA sequence in Trypanosoma brucei. Cell (1984) 2.89
Sequence requirements for premature termination of transcription in the human c-myc gene. Cell (1988) 2.87
CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J Immunol (1990) 2.84
Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J Biol Chem (2001) 2.76
Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer. Science (1990) 2.76
Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol (1996) 2.69
Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking. Science (1991) 2.65
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62
Nucleotide sequence relationships of avian RNA tumor viruses: measurement of the deletion in a transformation-defective mutant of Rous sarcoma virus. J Virol (1974) 2.61
Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol (1993) 2.55
Propagation of globin DNAase I-hypersensitive sites in absence of factors required for induction: a possible mechanism for determination. Cell (1982) 2.54
Interaction of HMG 14 and 17 with actively transcribed genes. Cell (1980) 2.52
Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci U S A (2000) 2.46
Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes. Proc Natl Acad Sci U S A (1999) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol (2000) 2.36
Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol Cell Biol (1986) 2.34
Absence of B7-dependent responses in CD28-deficient mice. Immunity (1994) 2.32
Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev (1996) 2.30
The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ (2000) 2.29
AU RNA-binding factors differ in their binding specificities and affinities. J Biol Chem (1992) 2.25
Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol (2000) 2.24
The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol Cell (1998) 2.22
CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood (1990) 2.21
Participation of the human beta-globin locus control region in initiation of DNA replication. Science (1995) 2.18
Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3. Mol Cell Biol (1996) 2.17